News Aptar buys digital health partner Healint More evidence of consolidation in the digital health category has come with the news that Aptar has bought Singapore’s Healint, which develops patient support apps as well
R&D Importance of diversity in pharma and clinical trials “Diversity.” It’s a word that is very commonly thrown around right now, not just in pharma and healthcare but across all industries.
R&D Assumptions to evidence: How NIHR project is solidifying UK’... Remote, virtual, or decentralised clinical trials are nothing new, but COVID-19 catapulted the model into the mainstream.
Digital Post-ASCO 25: Pamela Tenaerts on CGTs and digital-first long... In a post-ASCO 2025 conversation, pharmaphorum web editor Nicole Raleigh spoke with Dr Pamela Tenaerts, chief medical officer at Medable.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face